2-73258990-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001371389.2(FBXO41):c.2620G>A(p.Gly874Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000164 in 1,581,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001371389.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO41 | NM_001371389.2 | c.2620G>A | p.Gly874Ser | missense_variant | Exon 13 of 13 | ENST00000520530.3 | NP_001358318.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO41 | ENST00000520530.3 | c.2620G>A | p.Gly874Ser | missense_variant | Exon 13 of 13 | 5 | NM_001371389.2 | ENSP00000430968.2 | ||
FBXO41 | ENST00000295133.9 | c.2620G>A | p.Gly874Ser | missense_variant | Exon 12 of 12 | 1 | ENSP00000295133.6 | |||
FBXO41 | ENST00000521871.5 | c.2620G>A | p.Gly874Ser | missense_variant | Exon 13 of 13 | 5 | ENSP00000428646.1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000133 AC: 26AN: 196122Hom.: 0 AF XY: 0.000132 AC XY: 14AN XY: 106280
GnomAD4 exome AF: 0.000162 AC: 232AN: 1429334Hom.: 0 Cov.: 31 AF XY: 0.000154 AC XY: 109AN XY: 708150
GnomAD4 genome AF: 0.000177 AC: 27AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2620G>A (p.G874S) alteration is located in exon 12 (coding exon 12) of the FBXO41 gene. This alteration results from a G to A substitution at nucleotide position 2620, causing the glycine (G) at amino acid position 874 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at